AstraZeneca To Eliminate 1,400 Jobs In Europe Even As It Expands In China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - AstraZeneca is expanding its main pharmaceutical manufacturing facility and logistics center in China even as the company prepares to close some smaller sites in Spain, Belgium and Sweden, according to AstraZeneca executives in the United Kingdom and China
You may also be interested in...
China's Medical Exports And Imports Nearly Double In First Half 2011
SHANGHAI - During the first half of 2011, China posted strong export and import growth in its medical products, which include pharmaceutical, active pharmaceutical ingredients, medical devices and traditional Chinese medicines, according to an Aug. 11 report from China's Chamber of Commerce
China's Medical Exports And Imports Nearly Double In First Half 2011
SHANGHAI - During the first half of 2011, China posted strong export and import growth in its medical products, which include pharmaceutical, active pharmaceutical ingredients, medical devices and traditional Chinese medicines, according to an Aug. 11 report from China's Chamber of Commerce
Investment Analysts Call On Western Drug Titans To Become More Transparent On Absolute Sales, Profit Levels In Emerging Markets
BEIJING - The globe's leading pharmaceutical players should become more transparent about precise sales and profit levels across emerging markets, including China, rather than issue vague statements about double-digit growth in these regions without providing base figures, according to investment analysts